Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.
Funding
Indonesia-based coffeehouse chain operator Kopi Kenangan reached a $96m first close today for its series C funding featuring investors including internet company Kunlun. Investment firm Tybourne Capital Management led the tranche completed at a valuation above $1bn, investing alongside Horizons Ventures, B Capital and Falcon Edge Capital.
China-based drug discovery platform QureBio raised RMB200m ($31m) in a series B round on Thursday led by financial services firm Bank of Communications’ Bocom International unit. Oriza Holdings, Spinnotec, Longmen Capital and Tianfu Sanjiang Capital were also among the participants.
Japan-based digital fan engagement system operator Ventus received ¥275m ($21.4m) in September this year from multiple corporates, it disclosed last Monday. The investors included Anobaka, G-Startup Fund, OLM Ventures, Voyage Ventures, SMBC Venture Capital and Mizuho Capital, part of mobile game publisher KLab, education services provider Globis, animation studio Oriental Light and Magic, travel technology provider Voyage as well as financial services…
